Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • References
  • Version history
Article has an altmetric score of 15

See more details

Blogged by 1
Referenced in 3 patents
11 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Letter to the Editor Free access | 10.1172/JCI14455

The effect of salicylates on insulin sensitivity

Mihai G. Netea,1 Cees J. Tack,1 Paetrick M. Netten,2 Jos A. Lutterman,1 and Jos W.M. Van der Meer1

1Department of Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands2Department of Internal Medicine, Bosch Medicentrum, ‘s-Hertogenbosch, The Netherlands

Address correspondence to: Mihai G. Netea, Department of Medicine (541), University Medical Center St. Radboud, Geert Grooteplein 8, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614652; Fax: 31-24-3541734; E-mail:M.Netea@aig.azn.nl.

Find articles by Netea, M. in: JCI | PubMed | Google Scholar

1Department of Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands2Department of Internal Medicine, Bosch Medicentrum, ‘s-Hertogenbosch, The Netherlands

Address correspondence to: Mihai G. Netea, Department of Medicine (541), University Medical Center St. Radboud, Geert Grooteplein 8, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614652; Fax: 31-24-3541734; E-mail:M.Netea@aig.azn.nl.

Find articles by Tack, C. in: JCI | PubMed | Google Scholar

1Department of Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands2Department of Internal Medicine, Bosch Medicentrum, ‘s-Hertogenbosch, The Netherlands

Address correspondence to: Mihai G. Netea, Department of Medicine (541), University Medical Center St. Radboud, Geert Grooteplein 8, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614652; Fax: 31-24-3541734; E-mail:M.Netea@aig.azn.nl.

Find articles by Netten, P. in: JCI | PubMed | Google Scholar

1Department of Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands2Department of Internal Medicine, Bosch Medicentrum, ‘s-Hertogenbosch, The Netherlands

Address correspondence to: Mihai G. Netea, Department of Medicine (541), University Medical Center St. Radboud, Geert Grooteplein 8, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614652; Fax: 31-24-3541734; E-mail:M.Netea@aig.azn.nl.

Find articles by Lutterman, J. in: JCI | PubMed | Google Scholar

1Department of Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands2Department of Internal Medicine, Bosch Medicentrum, ‘s-Hertogenbosch, The Netherlands

Address correspondence to: Mihai G. Netea, Department of Medicine (541), University Medical Center St. Radboud, Geert Grooteplein 8, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614652; Fax: 31-24-3541734; E-mail:M.Netea@aig.azn.nl.

Find articles by Van der Meer, J. in: JCI | PubMed | Google Scholar

Published December 1, 2001 - More info

Published in Volume 108, Issue 11 on December 1, 2001
J Clin Invest. 2001;108(11):1723–1724. https://doi.org/10.1172/JCI14455.
© 2001 The American Society for Clinical Investigation
Published December 1, 2001 - Version history
View PDF

Insulin resistance, a characteristic feature of type 2 diabetes, is associated with central obesity, hypertension, dyslipidemia, and cardiovascular disease (and death) (1). The mechanism of insulin resistance is complex and largely unknown. Both in animals and in humans, however, insulin resistance can be induced by lipid infusion. In a recent issue of the JCI, Kim and colleagues presented new data on the mechanisms responsible for the induction of insulin resistance by lipids. In an elegant set of experiments, they show that activation of IKK-β is important in fat-induced insulin (2). High-dose salicylate prevents the fat-induced defects in insulin signaling. Based on these findings, the authors suggest that “salicylates represent a potentially novel class of therapeutic agents for type 2 diabetes” (2).

Although the carefully performed study by Kim et al. provides new insight into the mechanisms of fat-induced insulin resistance, we would like to caution against the preliminary conclusion concerning beneficial effects of salicylates on insulin resistance. First of all, in contrast to the findings of Kim et al. in the triglyceride (TG) infusion model in the rat, earlier studies in human volunteers using hyperglycemic clamp techniques reported increased insulin resistance by salicylate compounds (3, 4). These findings suggest that the effects of salicylates may depend on the experimental model, and possibly on the species studied.

There are also strong theoretical arguments that salicylates have deleterious effects on insulin resistance. Similar to TGs (or fatty acids), the proinflammatory cytokine TNF-α synthesized by adipocytes is a central factor in the pathogenesis of insulin resistance (5). As underlined also by Kim et al., there is significant overlap between the intracellular events induced by fatty acids and TNF in insulin-sensitive tissues: both activate IKK-β and decrease IRS-1 tyrosine phosphorylation, and both increase intracellular ceramide concentrations, which leads to inhibition of Akt/protein kinase B activation and impaired GLUT-4 translocation (these relationships are outlined in Figure 1) (6–8). The effects of salicylates on TNF-induced insulin resistance are completely opposite to those reported by Kim and colleagues on fat-induced insulin resistance. TNF induces the synthesis of prostaglandins (PGs), which function as a negative feedback mechanism by inhibiting the upstream TNF production (9). We and others have shown in healthy volunteers that administration of aspirin or indomethacin, both strong inhibitors of PG synthesis, enhances TNF production capacity at least twofold (10, 11), which can negatively affect insulin sensitivity. In addition, PGs stimulate synthesis of leptin, an adipocytokine known to decrease insulin resistance through improvement of IRS-1−associated phosphatidylinositol (PI) 3-kinase activity (12, 13). Although not yet experimentally tested, inhibition of PG synthesis by salicylate compounds may also negatively influence insulin sensitivity by inhibition of leptin release. Thus, aspirin could increase insulin resistance through at least two mechanisms mediated by the inhibition of PG synthesis, namely the upregulation of TNF synthesis and the inhibition of leptin release (Figure 1). There are other important endogenous factors modulating the resistance to insulin: adiponectin reverses insulin resistance, possibly in part by inhibition of TNF synthesis, whereas resistin impairs glucose tolerance and insulin action (12, 14). The influence of salicylates on the modulation of these proteins is not known.

The effects of salicylates on insulin resistance. There is significant overFigure 1

The effects of salicylates on insulin resistance. There is significant overlap between the intracellular events induced by TGs (or FFAs) and TNF regarding the mechanisms of insulin resistance. Both stimuli activate IKK-β and decrease insulin-induced tyrosine phosphorylation of IRS-1; both increase intracellular ceramide concentrations, which leads to inhibition of Akt/protein kinase B activation and inhibition of GLUT-4 translocation. These effects induce a state of insulin resistance. The effects of salicylate compounds on these pathways may be divergent. That is, they may improve insulin resistance by blocking the activation of IKK-β (top), or they may worsen insulin resistance by inhibiting PG synthesis and thus potentiating TNF release (bottom). In addition, inhibition of PG will decrease synthesis of leptin, which is known to improve insulin sensitivity by stimulating IRS-1–associated PI 3-kinase activity. The beneficial effect of leptin on insulin action is thus decreased (bottom).

In conclusion, the influence of salicylate compounds on insulin sensitivity is multifactorial and involves both beneficial and deleterious effects. This should not preclude patients from taking low-dose aspirin to prevent cardiovascular disease (15), but more basal and clinical studies are needed before recommending higher dosages of salicylates for the treatment of type 2 diabetes itself.

References
  1. Reaven, GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993. 44:121-131.
    View this article via: PubMed CrossRef Google Scholar
  2. Kim, JK, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001. 108:437−446.
    View this article via: JCI PubMed Google Scholar
  3. Newman, WP, Brodows, RG. Aspirin causes tissue insensitivity to insulin in normal man. J Clin Endocrinol Metab 1983. 57:1102-1106.
    View this article via: PubMed Google Scholar
  4. Giugliano, D, Sacca, L, Scognamiglio, G, Ungaro, B, Torella, R. Influence of acetylsalicylic acid on glucose turnover in normal man. Diabetes Metab 1982. 8:279-282.
  5. Uysal, KT, Wiesbrock, SM, Marino, MW, Hotamisligil, GS. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997. 389:610-614.
    View this article via: PubMed CrossRef Google Scholar
  6. Shulman, GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000. 106:171-176.
    View this article via: JCI PubMed CrossRef Google Scholar
  7. Hotamisligil, GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 1999. 107:119-125.
    View this article via: PubMed Google Scholar
  8. Kanety, H, Hemi, R, Papa, MZ, Karasik, A. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 1996. 271:9895-9897.
    View this article via: PubMed CrossRef Google Scholar
  9. Renz, H, Gong, J-H, Schmidt, A, Nain, M, Gemsa, D. Release of tumor necrosis factor-α from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988. 141:2388-2393.
    View this article via: PubMed Google Scholar
  10. Endres, S, Whitaker, RED, Ghorbani, R, Meydani, SN, Dinarello, CA. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1β and of tumour necrosis factor-α ex vivo. Immunology 1996. 87:264-270.
    View this article via: PubMed CrossRef Google Scholar
  11. Netea, MG, Puren, AJ, Dinarello, CA. A short course of oral aspirin increases IL-18-induced interferon-gamma production in whole-blood cultures. Eur Cytokine Netw 2000. 11:379-382.
    View this article via: PubMed Google Scholar
  12. Yamauchi, T, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001. 7:941-946.
    View this article via: PubMed CrossRef Google Scholar
  13. Kim, Y-B, Uotani, S, Pierroz, DD, Flier, JS, Kahn, BB. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 2000. 141:2328-2339.
    View this article via: PubMed CrossRef Google Scholar
  14. Steppan, CM, et al. The hormone resistin links obesity to diabetes. Nature 2001. 409:307-312.
    View this article via: PubMed CrossRef Google Scholar
  15. Rolka, DB, Fagot-Campagna, A, Venkat Narayan, KM. Aspirin use among adults with diabetes. Estimates from the Third National Health and Nutrition Examination. Diabetes Care 2001. 24:197-201.
    View this article via: PubMed CrossRef Google Scholar
Version history
  • Version 1 (December 1, 2001): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 15
  • Article usage
  • Citations to this article

Go to

  • Top
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 3 patents
11 readers on Mendeley
See more details